3 Lesser-Known Small-Cap Stocks Facing Uncertainties

Why Small-Cap Stocks Are a Double-Edged Sword

Small-cap stocks often fly under Wall Street’s radar, giving early investors a potential advantage. However, these companies also carry greater risks due to their smaller size and limited resources compared to industry giants.

Navigating these challenges can be tough, even for experienced investors. That’s why StockStory was created—to help you distinguish between promising opportunities and those best avoided. Below, we highlight three small-cap stocks to steer clear of, along with some alternatives worth your attention.

SunOpta (STKL)

Market Capitalization: $768.1 million

SunOpta (NASDAQ:STKL) is dedicated to producing clean-label, sustainable food and beverage products, focusing on organic sourcing, processing, and packaging.

Reasons to Avoid SunOpta

• Over the past three years, annual sales have dropped by 1.6%, indicating unfavorable consumer trends.
• With revenues of $792.4 million, SunOpta operates on a smaller scale than its larger competitors, limiting its distribution reach.
• The company faces intense competition with easily replaceable products, resulting in a modest gross margin of 15.4%, which requires higher sales volumes to compensate.

SunOpta shares currently trade at $6.47, reflecting a forward P/E of 36.6.

Leggett & Platt (LEG)

Market Capitalization: $1.56 billion

Established in 1883, Leggett & Platt (NYSE:LEG) manufactures a wide range of products and components for multiple industries.

Why Leggett & Platt May Disappoint

• Sales have decreased by 1.1% annually over the past five years, suggesting limited customer enthusiasm.
• The company’s weak free cash flow margin of 6% over the last two years restricts its ability to reinvest or reward shareholders.
• Declining returns on capital from an already low base indicate recent investments have not created value.

Leggett & Platt is priced at $11.15 per share, with a forward P/E of 10.6.

Oaktree Specialty Lending (OCSL)

Market Capitalization: $1.01 billion

Oaktree Specialty Lending (NASDAQ:OCSL), managed by Oaktree Capital Management, offers tailored financing solutions to mid-sized companies across diverse sectors.

Why We’re Not Bullish on OCSL

• Sales have fallen by 12.4% annually over the past two years, showing weak market demand for its offerings.
• Earnings per share have declined at a faster rate than revenue, indicating shrinking profitability.
• Loan losses and capital returns have reduced tangible book value per share by 4.5% annually over the last five years.

Oaktree Specialty Lending trades at $11.29 per share, with a forward P/E of 7.7.

Top Stocks for Every Market Environment

Don’t Miss: The 9 Best Market-Beating Stocks. The most successful stocks consistently outperform the market, boasting impressive revenue growth, expanding free cash flow, and superior returns on capital. These companies have already been recognized by the market for their achievements.

According to our AI-driven platform, the momentum isn’t slowing down. Discover which nine stocks made our list this week—absolutely free.

Past selections include well-known names like Nvidia, which soared 1,326% from June 2020 to June 2025, as well as lesser-known companies such as Kadant, which delivered a 351% return over five years.